Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

Rewriting endogenous human transcripts with -splicing

“A CRISPR-dCas13 RNA-editing tool to study alternative splicing”

A CRISPR-dCas13 RNA-editing tool to study alternative splicing

Programmable RNA writing with trans-splicing

CRISPR artificial splicing factors

RNA editing with CRISPR-Cas13

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Precise transcript targeting by CRISPR-Csm complexes

Programmable RNA base editing with photoactivatable CRISPR-Cas13

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Disrupting Protein Expression with Double-Clicked sgRNA-Cas9 Complexes: A Modular Approach to CRISPR Gene Editing

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system

Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X

Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing